BEAT Stock Analysis: Buy, Sell, or Hold?

BEAT - Heartbeam, Inc. Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$1.45
-0.06 (-3.97%) β–Ό
WAIT
LOW Confidence
Protect Your BEAT Gains
Last Updated: January 30, 2026
Earnings: Mar 12, 2026

Get Alerted When BEAT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BEAT is down 19.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

In-depth Analysis How we analyze

Valuation Analysis: BEAT is currently trading at $1.45, which is considered oversold relative to its 30-day fair value range of $1.89 to $2.62.

Technical Outlook: Technically, BEAT is in a uptrend. The price is currently testing key support at $1.41. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.62 (+206.3%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $1.89 - $2.62
Company Quality Score 50/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 77.4%

Protect Your Profits

Holding BEAT? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.0%)
  • BULLISH: Trading 206.3% below Wall St target ($4.62)
  • WARNING: Recommendation downgraded due to -19.9% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $1.89 - $2.62
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $1.41
Resistance Level $2.24
Current Trend Uptrend

Fundamental Context

Forward P/E (Next Year Est.) -3.02
Wall Street Target $4.63 (+206.3%)
Last updated: January 31, 2026 11:43 AM ET
Data refreshes hourly during market hours. Next update: 12:43 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Health Information Services Stocks

Top-rated stocks in Health Information Services by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VEEV
Veeva Systems Inc Class A
BUY
32 analysts
$310 54 HOLD
PRVA
Privia Health Group Inc
STRONG BUY
21 analysts
$31 57 HOLD
GEHC
GE HealthCare Technologi…
STRONG BUY
21 analysts
$90 60 HOLD
PHR
Phreesia Inc
STRONG BUY
15 analysts
$29 48 HOLD
HQY
HealthEquity Inc
STRONG BUY
14 analysts
$119 55 HOLD

Advanced BEAT Option Strategies

Professional options setups generated by AI based on today's BEAT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BEAT

BEAT Technical Chart BEAT Price Prediction BEAT Earnings Date BEAT Investment Advisor BEAT Fair Price Analyzer BEAT Options Advisor BEAT Options Chain BEAT Options Analysis BEAT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals